B20 | Evaluation of four chemotherapy regimens for treatment of AIDS-associated Kaposi's sarcoma in Kenya: a cost-effectiveness analysis | E-poster | Malignancies (AIDS and non-AIDS related) |
B20 | Cancer among people living with HIV in Ontario, Canada: a population-based matched cohort study among individuals with and without HIV | E-poster | Malignancies (AIDS and non-AIDS related) |
B20 | Efficacy and safety of topical trichloroacetic acid vs. electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive patients (TECAIN): a randomized controlled trial | E-poster | Malignancies (AIDS and non-AIDS related) |
B2 | The VACS index predicts five year mortality among people living with HIV In Thailand | E-poster | Morbidity, mortality and life expectancy |
B2 | Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapy | E-poster | Morbidity, mortality and life expectancy |
B2 | High-dimensional polychromatic flow cytometry reveals mucosal-homing as a putative biomarker of natural killer cells in persons aging with or without HIV | E-poster | Morbidity, mortality and life expectancy |
B19 | Factors associated with severity of Edinburgh Postnatal Depression Screen (EPDS) and optimal cut-off of EPDS for diagnosis of depression and anxiety among postpartum HIV- positive women in Lusaka, Zambia | On-demand oral abstract session | Depression and other psychiatric manifestations |
B19 | Psychological stress is associated with carotid inflammation in persons with treated HIV infection | E-poster | Depression and other psychiatric manifestations |
B19 | Changes in depression, anxiety and substance use during the COVID-19 pandemic in an HIV primary care population in the United States | E-poster | Depression and other psychiatric manifestations |
B19 | Resilience and frailty in people living with HIV during the COVID era: two complementary constructs? | E-poster | Depression and other psychiatric manifestations |